Legacy Capital Wealth Partners, LLC Abb Vie Inc. Transaction History
Legacy Capital Wealth Partners, LLC
- $574 Million
- Q3 2024
A detailed history of Legacy Capital Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Legacy Capital Wealth Partners, LLC holds 4,469 shares of ABBV stock, worth $896,079. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,469
Previous 4,098
9.05%
Holding current value
$896,079
Previous $702,000
25.64%
% of portfolio
0.15%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...